Application

TIRBEXLAS

Eli Lilly and Company

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88874527
Filing Date: 04/16/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88874527
MARK INFORMATION
*MARK TIRBEXLAS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TIRBEXLAS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Eli Lilly and Company
*MAILING ADDRESS Lilly Corporate Center
*CITY Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
46285
PHONE 317-651-1346
FAX 317 276 1919
*EMAIL ADDRESS longbottom_bruce@lilly.com
WEBSITE ADDRESS www.lilly.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT The mark is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME Bruce W. Longbottom
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 46285
PHONE 317-651-1346
FAX 317 276 1919
EMAIL ADDRESS trademarks@lilly.com
OTHER APPOINTED ATTORNEY John R. Rudolph, Steven P. Caltrider, Gilbert T. Voy, Tonya L. Combs
CORRESPONDENCE INFORMATION
NAME Bruce W. Longbottom
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@lilly.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) longbottom_bruce@lilly.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Assistant General Counsel
SIGNATORY'S PHONE NUMBER 317-651-1346
DATE SIGNED 04/16/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88874527
Filing Date: 04/16/020

To the Commissioner for Trademarks:

MARK: TIRBEXLAS (Standard Characters, see mark)
The literal element of the mark consists of TIRBEXLAS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317-651-1346(phone)
      317 276 1919(fax)
      longbottom_bruce@lilly.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Miscellaneous Statement
The mark is a coined, non-dictionary word with no English translation.


For informational purposes only, applicant's website address is: www.lilly.com

The owner's/holder's proposed attorney information: Bruce W. Longbottom. Other appointed attorneys are John R. Rudolph, Steven P. Caltrider, Gilbert T. Voy, Tonya L. Combs. Bruce W. Longbottom of Eli Lilly and Company, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317-651-1346(phone)
      317 276 1919(fax)
      trademarks@lilly.com

Bruce W. Longbottom submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Bruce W. Longbottom
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /blongbottom/   Date: 04/16/2020
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Payment Sale Number: 88874527
Payment Accounting Date: 04/16/2020

Serial Number: 88874527
Internet Transmission Date: Thu Apr 16 12:40:10 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2020041612401065
1650-88874527-710f4c695c35d9b8177f26ed0c
4dc2612886a66e53dfff5a78bbe2ec96b31f9ac4
-DA-40100313-20200415190029338984

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed